Vas Narasimhan, Novartis CEO (Simon Dawson/Bloomberg via Getty Images)
With Sandoz continuing to drag on Novartis, Vas Narasimhan says he may finally be ready for a sale or spinoff
After years of rehab work aimed at getting Sandoz in fighting trim to compete in a market overshadowed by declining prices, CEO Vas Narasimhan took …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
